A functionally orthogonal estrogen receptor-based transcription switch specifically induced by a nonsteroid synthetic ligand

Chemistry and Biology

Volumn 12, Issue 8, 2005, Pages 883-893

  Gallinari, Paola ^a   Lahm, Armin ^a   Koch, Uwe ^a   Paolini, Chantal ^a   Nardi, Maria Chiara ^a   Roscilli, Giuseppe ^a   Kinzel, Olaf ^a   Fattori, Daniela ^a   Muraglia, Ester ^a   Toniatti, Carlo ^a   Cortese, Riccardo ^a   De Francesco, Raffaele ^a   Ciliberto, Gennaro ^a  

^a IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HYBRID PROTEIN; LIGAND; TRANSCRIPTION FACTOR;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; DRUG DESIGN; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KINETICS; METABOLISM; REPORTER GENE; YEAST;

AMINO ACID SUBSTITUTION; BINDING SITES; DRUG DESIGN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; KINETICS; LIGANDS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; YEASTS;

EID: 23944467530     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2005.05.018     Document Type: Article

References (32)

1. C. Toniatti, H. Bujard, R. Cortese, and G. Ciliberto Gene therapy progress and prospects: transcription regulatory systems Gene Ther. 11 2004 649 657
2. W. Weber, and M. Fussenegger Artificial mammalian gene regulation networks - novel approaches for gene therapy and bioengineering J. Biotechnol. 98 2002 161 187
3. M.J. Tsai, and B.W. O'Malley Molecular mechanisms of action of steroid/thyroid receptor superfamily members Annu. Rev. Biochem. 63 1994 451 486
4. Y. Wang, B.W. O'Malley Jr., S.Y. Tsai, and B.W. O'Malley A regulatory system for use in gene transfer Proc. Natl. Acad. Sci. USA 91 1994 8180 8184
5. Y. Wang, J. Xu, T. Pierson, B.W. O'Malley, and S.Y. Tsai Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator Gene Ther. 4 1997 432 441
6. R.V. Abruzzese, D. Godin, M. Burcin, V. Mehta, M. French, Y. Li, B.W. O'Malley, and J.L. Nordstrom Ligand-dependent regulation of plasmid-based transgene expression in vivo Hum. Gene Ther. 10 1999 1499 1507
7. R.R. Beerli, U. Schopfer, B. Dreier, and C.F. Barbas 3rd. Chemically regulated zinc finger transcription factors J. Biol. Chem. 275 2000 32617 32627
8. L. Xu, D. Zerby, Y. Huang, H. Ji, O.F. Nyanguile, J.E. de los Angeles, and M.J. Kadan A versatile framework for the design of ligand-dependent, transgene-specific transcription factor Mol. Ther. 3 2001 262 273
9. G. Roscilli, C.D. Rinaudo, M. Cimino, E. Sporeno, S. Lamartina, G. Ciliberto, and C. Toniatti Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor Mol. Ther. 6 2002 653 663
10. C.K. Osborne Tamoxifen in the treatment of breast cancer N. Engl. J. Med. 339 1998 1609 1618
11. G.H. Eltabbakh, and S.L. Mount Tamoxifen and the female reproductive tract Expert Opin. Pharmacother. 2 2001 1399 1413
12. R. Tedesco, J.A. Thomas, B.S. Katzenellenbogen, and J.A. Katzenellenbogen The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations Chem. Biol. 8 2001 277 287
13. Y. Shi, and J.T. Koh Selective regulation of gene expression by an orthogonal estrogen receptor-ligand pair created by polar-group exchange Chem. Biol. 8 2001 501 510
14. Y. Shi, and J.T. Koh Functionally orthogonal ligand-receptor pairs for the selective regulation of gene expression generated by manipulation of charged residues at the ligand-receptor interface of ERα and ERβ J. Am. Chem. Soc. 124 2002 6921 6928
15. Parker, D.L.J., Ratcliffe, R.W., Wilkening, R.R., and Wildonger, K.J. (November 2001). Estrogen receptor modulators. U.S. patent WO 200182923.
16. Wilkening, R., Parker, D.L.J., Wildonger, K.J., Meng, D., and Ratcliffe, R.W. (May 2002). Estrogen receptor modulators. U.S. patent WO 200241835.
17. A.M. Brzozowski, A.C. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G.L. Greene, J.A. Gustafsson, and M. Carlquist Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389 1997 753 758
18. A.C. Pike, A.M. Brzozowski, R.E. Hubbard, T. Bonn, A.G. Thorsell, O. Engstrom, J. Ljunggren, J.A. Gustafsson, and M. Carlquist Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist EMBO J. 18 1999 4608 4618
19. A.K. Shiau, D. Barstad, P.M. Loria, L. Cheng, P.J. Kushner, D.A. Agard, and G.L. Greene The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 95 1998 927 937
20. P. Neuner, R. Cortese, and P. Monaci Codon-based mutagenesis using dimer-phosphoramidites Nucleic Acids Res. 26 1998 1223 1227
21. P.S. Danielian, R. White, S.A. Hoare, S.E. Fawell, and M.G. Parker Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen Mol. Endocrinol. 7 1993 232 240
22. T.D. Littlewood, D.C. Hancock, P.S. Danielian, M.G. Parker, and G.I. Evan A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins Nucleic Acids Res. 23 1995 1686 1690
23. J.T. Koh Engineering selectivity and discrimination into ligand-receptor interfaces Chem. Biol. 9 2002 17 23
24. G.M. Anstead, K.E. Carlson, and J.A. Katzenellenbogen The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site Steroids 62 1997 268 303
25. W. Sippl Receptor-based 3D QSAR analysis of estrogen receptor ligands-merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods J. Comput. Aided Mol. Des. 14 2000 559 572
26. E.A. Althoff, and V.W. Cornish A bacterial small-molecule three-hybrid system Angew. Chem. Int. Ed. Engl. 41 2002 2327 2330
27. P.A. Clemons, B.G. Gladstone, A. Seth, E.D. Chao, M.A. Foley, and S.L. Schreiber Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors Chem. Biol. 9 2002 49 61
28. D.F. Doyle, D.A. Braasch, L.K. Jackson, H.E. Weiss, M.F. Boehm, D.J. Mangelsdorf, and D.R. Corey Engineering orthogonal ligand-receptor pairs from "near drugs" J. Am. Chem. Soc. 123 2001 11367 11371
29. M.B. Kumar, T. Fujimoto, D.W. Potter, Q. Deng, and S.R. Palli A single point mutant in ecdysone receptor leads to increased ligand specificity: implications for gene switch applications Proc. Natl. Acad. Sci. USA 99 2002 14710 14715
30. S.D. Liberles, S.T. Diver, D.J. Austin, and S.L. Schreiber Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen Proc. Natl. Acad. Sci. USA 94 1997 7825 7830
31. M. Gossen, S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard Transcription activation by tetracyclines in mammalian cells Science 268 1995 1766 1769
32. Ciliberto, G., De Francesco, R., Fattori, D., Gallinari, P., Lahm, A., Kinzel, O., Koch, U., Muraglia, E., Toniatti, C., and Cortese, R. (May 2005). Orthogonal Gene Switches. U.S. patent WO 05/040212.